Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis - Takeaways - DentalSpire

Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis

  • By

  • Yining Wang

  • Fei Wu

  • Hongfei Mo

  • Qinghua Yan

  • Hongjie Chu

  • Mengyan Wang

  • Yang Zhou

  • Huiting Yu

  • Shuyue Sun

  • Minna Cheng

  • Fan Wang

  • Yan Shi

  • January 16, 2026

  • 0 min

Share

  • 1

    The triglyceride-glucose (TyG) index is a reliable marker for assessing insulin resistance and mortality risk in individuals with type 2 diabetes.

  • 2

    Novel anthropometric indicators like body roundness index (BRI) and weight-adjusted waist index (WWI) may provide better risk assessment than traditional measures.

  • 3

    Combining the TyG index with innovative obesity measures can enhance mortality risk prediction in elderly patients with type 2 diabetes.

  • 4

    Renal dysfunction, indicated by decreased estimated glomerular filtration rate (eGFR), plays a significant role in the mortality risk associated with insulin resistance.

  • 5

    The study aims to identify optimal composite indices for mortality risk assessment in older Chinese patients with type 2 diabetes, focusing on integrating TyG and obesity measures.

Original Source(s)

Utilizing the triglyceride-glucose index alongside innovative anthropometric indicators to assess mortality risk in individuals with type 2 diabetes: a prospective cohort analysis

  • by Yining Wang, Fei Wu, Hongfei Mo, Qinghua Yan, Hongjie Chu, Mengyan Wang, Yang Zhou, Huiting Yu, Shuyue Sun, Minna Cheng, Fan Wang, Yan Shi

  • January 16, 2026

Related Content

Sex-Specific Determinants of the Ketone Body β-Hydroxybutyrate in the General Population

The obesity paradigm and outcome after STEMI: good news for all patients with overweight and moderate obesity

Who Decides When a Doctor Steps Back?

Cognitive decline, credentialing, and why “I’ll know” often isn’t enough.